IL1B and autoimmune disease: Anakinra (Kineret, Swedish Orphan Biovitrum AB, Stockholm, Sweden) is a recombinant form of the IL-1R antagonist that inhibits the activity of IL-1β and has been primarily used as a treatment for autoimmune diseases that involve dysregulated IL-1 signalling, such as rheumatoid arthritis [12].